S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.10%) $10.83
USD/GBP
(-0.12%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Evaxion Biotech A/S [EVAX]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

6.67% $ 3.20


Warning: Undefined array key 1 in /home/getagraph/public_html/signalbox.php on line 10
BUY 64424 min ago

@ $4.00

Issued: 13 Feb 2024 @ 15:29


Return: -20.00%


Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections...

Stats
Today's Volume 17 099.00
Average Volume 688 718
Market Cap 9.02M
EPS $0 ( 2023-12-18 )
Next earnings date ( $0 ) 2024-05-29
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.340
ATR14 $0.0360 (1.13%)

Evaxion Biotech A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evaxion Biotech A/S Financials

Annual 2022
Revenue: $0
Gross Profit: $-571 319 (0.00 %)
EPS: $-9.80
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.05
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.10
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-2.42

Financial Reports:

No articles found.

Evaxion Biotech A/S

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators